TheraRadar
← Back
Data updated: Jul 17, 2026

DISCOVERY THERAP

Generics
Pharmaceuticals

DISCOVERY THERAP is a generic drug manufacturer with 1 FDA-approved products.

2005
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

DISCOVERY THERAP's Key Drugs

DISCOVERY THERAP's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

DISCOVERY THERAP's Recent FDA Approvals

New NDA/BLA approvals for DISCOVERY THERAP over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

DISCOVERY THERAP's Therapeutic Areas

Disease areas where DISCOVERY THERAP has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

DISCOVERY THERAP Pipeline Snapshot

Active clinical trials for DISCOVERY THERAP across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling